Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-18

Clinical Trial Update: A Study to Assess Safety of Canagliflozin and Metformin Hydrochloride Combination Given as a Supplement to Diet and Exercise to Improve Blood Sugar Level in Indian Adult Participants With Diabetes [Phase 4]

View source ↗

Summary

Phase 4 study assessing the safety of a canagliflozin and metformin hydrochloride combination as an adjunct to diet and exercise in Indian adults with diabetes;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Canagliflozin (canagliflozin)
  • METFORMIN HYDROCHLORIDE (Metformin hydrochloride)

Snippet

Sponsor: Johnson & Johnson Private Limited | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2023-08-18